Synapsoft logo
AI Insights from Disclosures
Searching...
curacle co., ltd. 365270
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
curacle co., ltd. is a biotech venture company engaged in the research and development of treatments for various intractable diseases caused by vascular endothelial dysfunction and aging. The company has designated diseases with high medical differentiation, marketability, commercialization potential, and scalability as its core fields, and is building its pipeline and conducting research and development using its proprietary platform technology and open innovation.
Representative Director Yu Jaehyeon
Founded May 12, 2016
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 11011-6058485
Business number 740-81-00539
Phone Number 031-706-8300
Fax Number 031-755-0220
Website www.curacle.com
Company Address 23-1 Hyoryeong-ro, Seocho-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant